Gadolinium concentration analysis in brain phantom by X-ray fluorescence

Australasian Physical and Engineering Sciences in Medicine

Volumn 33, Issue 2, 2010, Pages 185-191

  Almalki, Musaed ^a,b   Majid, Samir Abdul ^c   Butler, Philip H ^a   Reinisch, Lou ^d  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d JACKSONVILLE STATE UNIVERSITY   (United States)

Author keywords

Brain tumor; Gadolinium; Gadolinium concentration; X ray fluorescence

Indexed keywords

BRAIN PHANTOMS; BRAIN TUMORS; CDTE DETECTOR; CONCENTRATION ANALYSIS; DIFFERENT SIZES; FLUORESCENCE PEAK; FLUORESCENCE SIGNALS; MULTI-CHANNEL ANALYZER; OBLATE SPHEROID; PHOTOGRAPHIC IMAGING; SCATTERED X-RAYS; X RAY FLUORESCENCE;

CADMIUM COMPOUNDS; CONCENTRATION (PROCESS); FLUORESCENCE; METEOROLOGICAL INSTRUMENTS; TUMORS; X RAYS;

GADOLINIUM;

GADOLINIUM; GADOLINIUM PENTETATE;

ARTICLE; BIOLOGICAL MODEL; BRAIN; BRAIN TUMOR; HUMAN; IMAGE QUALITY; METABOLISM; NEUTRON CAPTURE THERAPY; RADIATION EXPOSURE; RADIOGRAPHY; SPECTROMETRY;

BRAIN; BRAIN NEOPLASMS; GADOLINIUM; GADOLINIUM DTPA; HUMANS; MODELS, BIOLOGICAL; NEUTRON CAPTURE THERAPY; PHANTOMS, IMAGING; SPECTROMETRY, X-RAY EMISSION;

EID: 77958133041     PISSN: 01589938     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13246-010-0020-x     Document Type: Article

References (14)

1. Shih JL, Brugger RM (1992) Gadolinium as a neutron capture therapy agent. Med Phys 19(3):733-744
2. Harms AA, Norman GR (1972) The role of internal conversion electrons in gadolinium-exposure neutron imaging. J Appl Phys 43(7):3209-3212
3. Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. Am J Roentgenol 142:619-624
4. Allen BJ, McGregor BJ, Martin RF (1989) Neutron capture therapy with gadolinium-157. Strahlenther onkol 165:156-157
5. Miller GA, Hertel NE, Wehring BW, Hornton JL (1993) Gadolinium neutron capture therapy. Nucl Technol 103:320-331
6. Ichikawa H, Watanabe T, Tokumitsu H, Fukumori Y (2007) Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy. Curr Drug Deliv 4(2):131-140
7. Carlsson J, Forssell-Aronsson E, Glimelius B (2002) Radiation therapy through activation of stable nuclides. Acta Oncological 41(7-8):629-634
8. Klykov SA, Ul'yanenko SE, Matusevich ES, Kurachenko YuA, Dulin VA (2004) Tissue absorbed dose from a gadolinium layer irradiated with neutrons. At Energy 96(6):430-433
9. Brugger RM, Shih JA (1989) Evaluation of Gadolinium-57 as a neutron capture therapy agent. Strahlenther onkol 165(2-3): 153-156
10. Yoshida K, Furuse M, Kaneoke Y, Saso K, Inao S, Motegi Y, Ichihara K, Izawa A (1989) Assessment of T1 time course changes and tissue blood ratios after Gd-DTPA administration in brain tumors. Magn Reson Imaging 7(1):9-15
11. Bartolini ME, Pekar J, Chettle DR, McNeill F, Scott A, Sykes J, Prato FS, Moran GR (2003) An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis. Magn Reson Imaging 21(5):541-544
12. Shih JL, Brugger RM (1992) Gadolinium as a neutron capture therapy agent. In: Allen BJ, Moore DE, Harrington BV (eds) Progress in neutron capture therapy for cancer. Plenum Press, New York, pp 183-186
13. Shapero J (1981) Radiation protection. A guide for scientists and physicians, 2nd edn. Harvard University Press, Cambridge, p 232
14. Haar PJ, Broaddus WC, Chen ZJ, Fatouros PP, Gillies GT, Corwin FD (2010) Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imagine and emission spectroscopy. Phys Med Biol pp 3451- 3465